Computer-guided design, synthesis, and protein kinase C affinity of a new salicylate-based class of bryostatin analogs.

ABSTRACT: Bryostatin 1 is in clinical trials for the treatment of cancer and Alzheimer's disease and is a candidate for a first-in-class approach to HIV/AIDS eradication. It is neither readily available nor optimally suited for clinical use. Using a function oriented synthesis strategy, a new class of bryostatin-inspired analogs was designed with a simplified salicylate-derived subunit, enabling step-economical synthesis (23 total steps) of agents exhibiting bryostatin-like affinity to protein kinase C (PKC).

SUBMITTER: Wender PA 

PROVIDER: S-EPMC4334246 | biostudies-literature | 2014 Oct

REPOSITORIES: biostudies-literature